ArticleJournal of medicinal chemistry2021

Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants.

Desaboini Nageswara Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.